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(p=0.04). Finally, higher CMV-IgG correlated with diffused cutaneous SSc form
(p=0.023) and nephropathy (p=0.036).
Conclusions: The seroprevalence of EBV and CMV positivity was found signifi-
cantly higher in the sample of SSc patients. EBV seropositivity (VCA-IgG) was
present nearly in the totality of patients (98%). Of relevance, the high presence of
CMV-IgG (93%) and CMV-IgM (44.9%) in SSc patients: the last correlated linearly
with higher pulmonary arterial pressure values. EBV and CMV infections, among
the supposed triggers in several autoimmune diseases, might also play a role in
SSc patients, at least with progressive disease.
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Background: Systemic sclerosis (SSc) is a chronic connective tissue disease
characterised by endothelial dysfunction, dysregulation of fibroblasts with exces-
sive fibrosis of the skin and internal organs and autoimmune abnormalities. Car-
dio-pulmonary manifestations are common in SSc and their detection in the early
stage of the disease as well as their careful follow-up are mandatory in order to
counteract their impact on the overall disease outcome. Despite the need of
establishing a proper methodology, literature provides few reports about this
issue.
Objectives: To evaluate the activity of our Cardio-Rheumatology Clinic in order
to optimise diagnostic management of cardio-pulmonary disease in SSc patients.
Methods: We retrospectively analysed data from 350 consecutive SSc patients
referred to our University-based Rheumatology Centre and SSc Unit (F/M 308/42;
lc/dcSSc 45/305; mean age 50.8±14.7 years; mean disease duration 10.9±7.0
years). All patients underwent general and cardio-pulmonary assessment, in par-
ticular they were evaluated in the Cardio-Rheumatology Clinic. The following
parameters were considered: physical examination; past and current drugs; blood
tests, in particular Erythrocyte sedimentation rate-ESR, C-reactive protein-CRP,
CPK enzymes, troponin, NT-pro-BNP, d-dimer, serum autoantibodies, 25-OH-
vitamin D; capillaroscopy; pulmonary function tests; high resolution scan of the
lungs (HRCT); standard electrocardiogram (ECG) and 24 hour Holter ECG moni-
toring; Doppler echocardiography; cardiac stress test; coronary angiography and
right heart catheterization (RHC); cardiac MRI and CT; vascular ultrasound
(intima-media-thickness, carotid-femoral and brachial-ankle pulse-wave-velocity).
The clinicians decided to perform these examinations according to clinical picture
and current methodologies.
Abstract AB0724 – Figure 1
Results: In the last 12 months we assessed 300 patients with 1st-level screening
(cardio-rheumatologic evaluation, standard ECG, Doppler echocardiography, pul-
monary function tests, thoracic imaging). Among 2nd-level, 30 procedures of
24 hour Holter ECG and 15 RHC tests were performed. Cardiac MRI, coronary
CT angiography and vascular ultrasound were assessed, when requested, as
3rd-level examinations (30 procedures). After 1 year we observed a mean time of
10±5 days between request and clinical cardio-rheumatologic evaluation, 20±12
days to perform 1st-level screening, 25±15 days to execute the 2nd-level exami-
nations. Figure-1 shows Cardio-Rheumatology algorithm for the management of
SSc cardio-pulmonary disease.
Conclusions: The activity of our Cardio-Rheumatology Clinic optimises the car-
dio-pulmonary SSc assessment, determining an early detection of these harmful
complications with reduced waiting times which are critical issues. Screening
algorithms are useful to stratify the risk and to establish the most appropriate diag-
nostic-therapeutic protocols, improving outcome of scleroderma patients. The
development of a cardio-pulmonary risk score and the standardisation of a patient
care approach, according to international quality indeces, could represent further
tools to optimise SSc management.
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Background: In Idiopathic Inflammatory Myopathies (MII), 18%–20% of patients
have dysphagia.
Objectives: To evaluate the frequency of dysphagia in patients with MII, associa-
tion with other manifestations of the disease, treatment and evolution.
To evaluate clinical characteristics and evolution of severe dysphagia.
To compare clinical characteristics and evolution of mild-moderate versus severe
dysphagia.
Methods: Retrospective, observational study. Patients with a diagnosis of MII
were included according to modified classification criteria of Bohan and Peter.
Demographic, clinical and complementary studies were recorded. Serious dys-
phagia was considered: contraindication of oral feeding. Descriptive statistics
were performed. Chi2 test, Student’s test or MannWhitney as appropriate.
Results: We included 91 of 106 patients evaluated from 1992 to 2017: 76%
female, mean age at diagnosis 48±14 years. 53% presented dysphagia: mild/
moderate 62.5% (30/48 pts), severe 37.5% (18/48). Idiopathic dermatomyositis
was the most frequent MII in these patients (71%). In patients with dysphagia,
proximal muscle weakness was 90%, weakness of neck muscles 45%, weakness
of respiratory muscles 27%.
A significant association was found between dysphagia and weakness of respira-
tory muscles, weak neck muscles, glucocorticoid pulses, gammaglobulin, grave
infections and death. (Data not shown in the summary).
In patients with severe dysphagia, we observed a significant association with the
requirement for mechanical ventilation, hospitalisation in an intensive care unit,
serious infections and death (table 1).
When comparing mild-moderate dysphagia vs severe dysphagia, a statistically
significant association was found with neck muscles weakness, respiratory
muscle weakness, glucocorticoid pulses, gamma globulin use, requirement for
mechanical ventilation, hospitalisation in an intensive care unit, severe infections
and mortality (table 2).
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